Canada markets close in 3 hours 41 minutes

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.45-0.10 (-0.57%)
As of 12:19PM EST. Market open.
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
121,890
96,148
42,087
25,000
Cost of Revenue
6,043
2,932
225
-
Gross Profit
115,847
93,216
41,862
-
Operating Expenses
Research Development
214,686
257,040
198,970
157,610
Selling General and Administrative
125,123
136,253
114,082
68,116
Total Operating Expenses
339,809
393,293
313,052
225,726
Operating Income or Loss
-223,962
-300,077
-271,190
-200,726
Interest Expense
-
0
0
67
Income Before Tax
-221,391
-299,964
-266,489
-192,256
Income from Continuing Operations
-221,391
-299,964
-266,489
-192,256
Net Income
-221,391
-299,964
-266,489
-192,256
Net Income available to common shareholders
-221,391
-299,964
-266,489
-192,256
Basic EPS
-
-5.16
-4.78
-4.48
Diluted EPS
-
-5.16
-4.78
-4.48
Basic Average Shares
-
58,084
55,781
42,869
Diluted Average Shares
-
58,084
55,781
42,869
EBITDA
-
-296,950
-264,184
-191,359